PACAP Goes Its Own Way in Migraine

Written By Neil Andrews

April 28, 2022

The migraine field has seen its share of recent successes in the treatment realm, particularly with drugs targeting either calcitonin gene-related peptide (CGRP), a peptide elevated in the serum during migraine attacks, or the CGRP receptor. Yet only about half of patients improve with anti-CGRP therapies, underscoring the need for new drug targets…

Read the full news story on the Migraine Science Collaborative

Neil Andrews
Previous

Location, Location, Location: Finding the Way to the Cell Types and Genes That Contribute to Migraine
Next

Painful Cold Sensing in Teeth: A New Role for a TRP Channel in a Well-Known Tooth Cell